CCL20 and melanoma: In univariable regression, sex, age group, AJCC stage, primary melanoma site, baseline therapy and elevated LDH levels at baseline did not significantly impact PFS, whereas ECOG, CCL20 group and elevated S100 at baseline increased the risk of an impaired PFS.